ArticleScientific reports2026
Mutational analysis of multidrug efflux pump (AcrAB-TolC) in Enterobacter cloacae isolates from clinical samples.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Gram-negative bacterial pathogens, multidrug efflux pump's role is being studied as one of the critical mechanisms to develop antibiotics resistance. The current study was designed to characterize the AcrAB-TolC efflux pump genes to determine its role in multidrug resistance of hospital-acquired Enterobacter cloacae. In this cross-sectional descriptive study, a total of 200 clinical samples were collected for the isolation of E. cloacae in district Peshawar, Khyber Pakhtunkhwa, Pakistan. The isolates were screened for antibiotic sensitivity testing. The molecular tools were utilized for the characterization of efflux pump AcrAB-TolC and its regulator genes with mutational analysis. Total 120 samples were found positive for the existence of multidrug resistant E. cloacae isolates. Nine (09) isolates were found positive for harboring AcrA, AcrB, and TolC genes while the regulator genes (RobA, RamA, and MarA) were detected in all 120 isolates. In AcrA gene (2) silent and (4) missense mutations were found while in AcrB (2) missense and in TolC (6) and in RobA (4) missense mutations were found. No mutation has been reported in the RamA and MarA gene. The mutations detected were novel and affected protein stability. The regulatory factors and efflux pump components of hospital-acquired E. cloacae are crucial in causing resistance to a variety of antibiotics, highlighting their significance as a possible target for innovative antimicrobial tactics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.